Table 2.
Study Participants’ Demographics and Baseline Characteristics for the Extended Study
| Vehicle OU Pilo 0%/Oxy 0% (N = 28) |
Low OU Pilo 0.5%/Oxy 0.0125% (N = 30) |
Medium OU Pilo 1.0%/Oxy 0.05% (N = 30) |
High OU Pilo 1.5%/Oxy 0.125% (N = 32) |
High NDE Pilo 1.5%/Oxy 0.125% (N = 31) |
Total (N = 151) | |
|---|---|---|---|---|---|---|
| Mean age (SD), yrs | 48.3 (3.9) | 49.4 (2.7) | 47.9 (3.9) | 49.2 (3.8) | 48.6 (3.6) | 48.6 (3.6) |
| Min, Max | 40, 55 | 43, 54 | 41, 54 | 41, 55 | 40, 55 | 40, 55 |
| Iris color brown, n (%) | 18 (64.3) | 19 (63.3) | 18 (60.0) | 20 (62.5) | 24 (77.4) | 99 (65.6) |
| Sex - male, % | 32.1 | 33.3 | 40 | 21.9 | 25.8 | 30.5 |
| Race, n (%) | ||||||
| White | 23 (82.1) | 23 (76.7) | 25 (83.3) | 23 (71.9) | 26 (83.9) | 120 (79.5) |
| Black | 3 (10.7) | 5 (16.7) | 5 (16.7) | 8 (25) | 4 (12.9) | 25 (16.6) |
| Asian | 0 | 1 (3.3) | 0 | 0 | 1 (3.2) | 2 (1.3) |
| American Indian or Alaska native | 1 (3.6) | 1 (3.3) | 0 | 0 | 0 | 2 (1.3) |
| Native Hawaiian/Pacific Islander | 1 (3.6) | 0 | 0 | 0 | 0 | 1 (0.7) |
| Multiple | 0 | 0 | 0 | 1 (3.1) | 0 | 1 (0.7) |
| Baseline UNVA, % | ||||||
| 20/40–20/80 | 71.4 | 66.7 | 60 | 59.4 | 71 | 65.6 |
| 20/100 or worse | 28.6 | 33.3 | 40 | 40.6 | 29 | 34.4 |
NDE = nondominant eye; OU = both eyes; Oxy = oxymetazoline; Pilo = pilocarpine; UNVA = uncorrected near visual acuity.